Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
1583
Takahashi K, Sato K
Establishment and characterization of a human neoplastic cell line (MFH-ino) derived from malignant fibrous histiocytoma of maxilla.Hum Cell
1991
4:51-7
PubMed ID: 1653597
4428
Yamashita H, Osaki M, Ardyanto TD, Osaki M, Yoshida H, Ito H.
Cyclooxygenase-2 in human malignant fibrous histiocytoma: correlations with intratumoral microvessel density, expression of vascular endothelial growth factor and thymidine phosphorylaseInt J Mol Med
2004
14(4):565-70
PubMed ID: 15375582
6475
Osaki M, Osaki M, Yamashita H, Shomori K, Yoshida H, Ito H.
Expression of minichromosome maintenance-2 in human malignant fibrous histiocytomas: Correlations with Ki-67 and P53 expression, and apoptosis.Int J Mol Med
2002
10(2):161-8
PubMed ID: 12119552